Eli Lilly and Company acquires manufacturing facility from Nexus Pharmaceuticals to expand U.S. capacity
Acquiring Company
Eli Lilly and Company
Acquired Company
Nexus Pharmaceuticals
IndianapolisIllinoisManufacturingBiotechnologyHealth CareMedicalPharmaceuticalManufacturingBiotechnologyHealth CareMedicalDescription
Eli Lilly and Company has entered into a definitive agreement to acquire a manufacturing facility from Nexus Pharmaceuticals, LLC. The acquisition of this FDA-approved facility in Pleasant Prairie, Wisconsin will further expand Lilly's global parenteral product manufacturing network, supporting increased demand for life-changing medicines. This strategic move demonstrates Lilly's commitment to growth, innovation, and serving patients around the world.
Quick answer
Eli Lilly and Company is acquiring Nexus Pharmaceuticals, announced April 22, 2024. Eli Lilly and Company is based in Indianapolis, Indiana, United States.
- How much did Eli Lilly and Company pay for Nexus Pharmaceuticals?
- The deal value was not disclosed.
- What does Eli Lilly and Company do?
- Lilly is a medicine company turning science into healing to make life better for people around the world.
- Where are Eli Lilly and Company and Nexus Pharmaceuticals based?
- Eli Lilly and Company is based in Indianapolis, Indiana, United States. Nexus Pharmaceuticals is based in Illinois, United States.
- Who are the decision-makers at Eli Lilly and Company?
- Fundz holds 5 contacts at Eli Lilly and Company. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Medical and Pharmaceutical
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Cycle Pharmaceuticals proposes to acquire Vanda Pharmaceuticals for $8.00 per share (June 6, 2024)
- AbbVie finalizes acquisition of Landos Biopharma, Inc. to advance treatment for ulcerative colitis and Crohn's disease (May 23, 2024)
- LCI completes acquisition of certain assets of Pfizer Pakistan Limited and Pfizer Inc. to enhance pharmaceutical portfolio (May 20, 2024)
- Future Pak proposes acquisition of Vanda Pharmaceuticals for $7.25 to $7.75 per share in cash (April 17, 2024)
- Juvisé Pharmaceuticals acquires rights to MS therapy Ponvory outside North America (April 2, 2024)
- Abbvie To Acquire Landos Biopharma, Further Strengthening Its Portfolio In Inflammatory And Autoimmune Diseases (March 25, 2024)
Who to call at Eli Lilly and Company, and when
When Eli Lilly and Company changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Eli Lilly and Company raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Eli Lilly and Company, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Eli Lilly and Company. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Eli Lilly and Company makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Nexus Pharmaceuticals?
Nexus Pharmaceuticals was acquired by Eli Lilly and Company, based in Indianapolis. The deal was reported on April 22, 2024. Lilly is a medicine company turning science into healing to make life better for people around the world. Eli Lilly and Company is publicly traded (LLY) and operates in Manufacturing.
When did Eli Lilly and Company acquire Nexus Pharmaceuticals?
Eli Lilly and Company's acquisition of Nexus Pharmaceuticals was reported on April 22, 2024. Eli Lilly and Company has entered into a definitive agreement to acquire a manufacturing facility from Nexus Pharmaceuticals, LLC. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Nexus Pharmaceuticals do?
Nexus Pharmaceuticals, LLC is a US-based healthcare company specializing in innovative processes to manufacture specialty and generic drugs. It is privately held, operating in Manufacturing, and is based in Illinois.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.